Renaissance Technologies’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,000
| Closed | -$120K | – | 3548 |
|
|
2025
Q1 | $120K | Sell |
14,000
-199,200
| -93% | -$1.71M | ﹤0.01% | 3164 |
|
|
2024
Q4 | $2.29M | Sell |
213,200
-30,600
| -13% | -$329K | ﹤0.01% | 1972 |
|
|
2024
Q3 | $1.38M | Sell |
243,800
-222,637
| -48% | -$1.26M | ﹤0.01% | 2249 |
|
|
2024
Q2 | $1.97M | Buy |
466,437
+386,537
| +484% | +$1.63M | ﹤0.01% | 1896 |
|
|
2024
Q1 | $407K | Buy |
+79,900
| New | +$407K | ﹤0.01% | 2954 |
|
|
2022
Q4 | – | Sell |
-367,100
| Closed | -$3.79M | – | 4109 |
|
|
2022
Q3 | $3.79M | Buy |
367,100
+9,300
| +3% | +$96K | 0.01% | 1609 |
|
|
2022
Q2 | $3.58M | Buy |
+357,800
| New | +$3.58M | ﹤0.01% | 1790 |
|
|
2021
Q1 | – | Sell |
-63,100
| Closed | -$341K | – | 3300 |
|
|
2020
Q4 | $341K | Buy |
+63,100
| New | +$341K | ﹤0.01% | 2988 |
|
|
2020
Q2 | – | Sell |
-407,400
| Closed | -$1.28M | – | 3426 |
|
|
2020
Q1 | $1.28M | Buy |
407,400
+325,859
| +400% | +$1.03M | ﹤0.01% | 2303 |
|
|
2019
Q4 | $211K | Buy |
+81,541
| New | +$211K | ﹤0.01% | 3184 |
|
|
2019
Q1 | – | Sell |
-18,109
| Closed | -$28K | – | 3437 |
|
|
2018
Q4 | $28K | Buy |
+18,109
| New | +$28K | ﹤0.01% | 3312 |
|